Commentary: Antiretroviral treatment for pregnant and breastfeeding women-the shifting paradigm

AIDS

Volumn 28, Issue SUPPL. 2, 2014, Pages

  Tsague, Landry ^a   Abrams, Elaine J ^b  

^a UNICEF   (United States)

^b Department of Medicine   (United States)

Author keywords

antiretroviral treatment; HIV infection; mother to child transmission; pregnancy

Indexed keywords

ANTIRETROVIRUS AGENT; EFAVIRENZ; EMTRICITABINE; LAMIVUDINE; NEVIRAPINE; TENOFOVIR; ZIDOVUDINE; BENZOXAZINE DERIVATIVE; RNA DIRECTED DNA POLYMERASE INHIBITOR;

ANTIVIRAL THERAPY; BREAST FEEDING; CD4 LYMPHOCYTE COUNT; DRUG SAFETY; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; NOTE; PREGNANCY; PREGNANT WOMAN; PRIORITY JOURNAL; PROPHYLAXIS; VERTICAL TRANSMISSION; ABNORMALITIES, DRUG-INDUCED; CENTRAL NERVOUS SYSTEM DISEASE; CHEMICALLY INDUCED; FEMALE; HIV INFECTIONS; PREGNANCY COMPLICATIONS, INFECTIOUS;

ABNORMALITIES, DRUG-INDUCED; BENZOXAZINES; CENTRAL NERVOUS SYSTEM DISEASES; FEMALE; HIV INFECTIONS; HUMANS; PREGNANCY; PREGNANCY COMPLICATIONS, INFECTIOUS; REVERSE TRANSCRIPTASE INHIBITORS;

EID: 84901427368     PISSN: 02699370     EISSN: 14735571     Source Type: Journal    
DOI: 10.1097/QAD.0000000000000234     Document Type: Note

References (20)

1. UNAIDS. Countdown to zero: global plan for the elimination of new HIV infections among children by 2015 and keeping their mothers alive, 2011-2015. Geneva, Switzerland: UNAIDS; 2011.
2. World Health Organization. Consolidated guidelines on the use of antiretroviral drugs for treating and preventing HIV infection. Geneva: World Health Organization; 2013, www.who.int/hiv/pub/guidelines/arv2013. [Accessed 26 January 2014]
3. World Health Organization. Antiretroviral therapy for HIV infection in adults and adolescents: recommendations for a public health approach [2010 revision]. Geneva: World Health Organization; 2010, http://whqlibdoc.who.int/ publications/2010/9789241599764-eng.pdf. [Accessed 26 January 2014]
4. UNAIDS. Report on the global AIDS epidemic 2013. Geneva, Switzerland: UNAIDS; 2013.
5. Kuhn L, Aldrovandi GM, Sinkala M, Kankasa C, Mwiya M, Thea DM. Potential impact of new WHO criteria for antiretroviral treatment for prevention of mother-to-child HIV transmission. AIDS 2010; 24:1374-1377.
6. Centers for Disease Control and Prevention (CDC). Impact of an innovative approach to prevent mother-to-child transmission of HIV: Malawi, July 2011-September 2012. MMWR Morb Mortal Wkly Rep 2013; 62:148-151.
7. Ahmed S, Kim MH, Abrams EJ. Risks and benefits of lifelong antiretroviral treatment for pregnant and breastfeeding women: a review of the evidence for the Option BR approach. Curr Opin HIV AIDS 2013; 8:474-489.
8. De Santis M, Carducci B, De Santis L, Cavaliere AF, Straface G. Periconceptional exposure to efavirenz and neural tube defects. Arch Intern Med 2002; 162:355.
9. Nightingale SL. From the food and drug administration. J Am Med Assoc 1998; 280:1472.
10. Ford N, Calmy A, Mofenson L. Safety of efavirenz in the first trimester of pregnancy: an updated systematic review and meta-analysis. AIDS 2011; 25:2301-2304.
11. Ekouevi DK, Coffie PA, Ouattara E, Moh R, Amani-Bosse C, Messou E, et al. Pregnancy outcomes in women exposed to efavirenz and nevirapine: an appraisal of the IeDEA West Africa and ANRS Databases, Abidjan, Cote d'Ivoire. J Acquir Immune Defic Syndr 2011; 56:183-187.
12. Wang L, Kourtis AP, Ellington S, Legardy-Williams J, Bulterys M. Safety of tenofovir during pregnancy for the mother and fetus: a systematic review. Clin Infect Dis 2013; 57:1773-1781.
13. World Health Organization. Technical update on treatment optimization: use of efavirenz during pregnancy: a public health perspective. Geneva, Switzerland: World Health Organization; 2012.
14. Sturt AS, Dokubo EK, Sint TT. Antiretroviral therapy (ART) for treating HIV infection in ART-eligible pregnant women. Cochrane Database Syst Rev 2010:CD008440.
15. Ford N, Calmy A, Andrieux-Meyer I, Hargreaves S, Mills EJ, Shubber Z. Adverse events associated with nevirapine use in pregnancy: a systematic review and meta-analysis. AIDS 2013; 27:1135-1143.
16. Ford N, Mofenson L, Shubber Z, Calmy A, Andrieux-Meyer I, Vitoria M, et al. Safety of efavirenz in the first trimester of pregnancy: an updated systematic review and meta-analysis. AIDS 2014; 28 (Supp 2):S123-S131.
17. Gibb DM, Kizito H, Russell EC, Chidziva E, Zalwango E, Nalumenya R, et al. Pregnancy and infant outcomes among HIV-infected women taking long-term ART with and without tenofovir in the DART trial. PLoS Med 2012; 9:e1001217.
18. Siberry GK, Williams PL, Mendez H, Seage GR 3rd, Jacobson DL, Hazra R, et al. Safety of tenofovir use during pregnancy: early growth outcomes in HIV-exposed uninfected infants. AIDS 2012; 26:1151-1159.
19. UNAIDS. 2013 progress report on the Global Plan: towards the elimination of new HIV infections among children by 2015 and keeping their mothers alive. Geneva, Switzerland: UNAIDS; 2013.
20. Abrams EJ, Myer L. Can we achieve an AIDS-free generation? Perspectives on the global campaign to eliminate new pediatric HIV infections. J Acquir Immune Defic Syndr 2013; 63 (Suppl 2):S208-S212.